Table 1.
Clinical description of the cohort.
| Demographics | Patients |
|---|---|
| Age (years) – mean (SD) | 63 (15) |
| Gender (male) – number (%) | 203 (64%) |
| Ethnic group – number (%) | |
| White | 192 (61%) |
| Asian | 87 (27%) |
| Black | 9 (3%) |
| mixed/others | 29 (9%) |
| Clinical characteristics | |
| ISARIC score – mean (SD) | 10 (4) |
| Admission NEWS-2 score – mean (SD) | 5 (2) |
| Maximum NEWS-2 score recorded during hospitalisation – mean (SD) | 9 (3) |
| Blood/sputum culture done – n (%) | 147 (46%) |
| Pathogen in those with culture | 14 (9%) |
| Coliform | 5 (3%) |
| Staphylococcus aureus | 7 (5%) |
| Pseudomonas | 2 (1%) |
| Stenotrophomonas maltophilia | 1 (1%) |
| Findings of COVID-19 on chest x-ray – n (%) | 259 (82%) |
| Treatment | |
| O2 – n (%) | 296 (93%) |
| Antibiotics – n (%) | 276 (87%) |
| Dexamethasone – n (%) | 276 (87%) |
| Remdesivir - n (%) | 9 (3%) |
| Tocilizumab – n (%) | 14 (4%) |
| Outcomes | |
| ITU – n (%) | 12 (4%) |
| Mortality – n (%) | 106 (33%) |
| Length of stay – mean (SD) | 13 (11) |